South Korea Drug Delivery Devices Market
South Korea Drug Delivery Devices Market to Reach Value of USD 0.7 Billion by 2030
Published | 21 October 2024
South Korea Drug Delivery Devices Market is flourishing because of rising healthcare spending and the government’s support to provide support to promote development and adoption of medical devices.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated South Korea Drug Delivery Devices Market size at USD 0.46 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects South Korea Drug Delivery Devices Market size to expand at a CAGR of 6.50% reaching a value of USD 0.70 billion by 2030. Growing elderly population, rising incidence of chronic illnesses, and growing emphasis on patient comfort and convenience are major growth factors for South Korea Drug Delivery Devices Market. In order to create efficient and cutting-edge drug delivery devices, businesses are heavily spending in pharmaceutical R&D, which is projected to propel the South Korea Drug Delivery Devices Market during the period in analysis.
Sample Request @ https://www.blueweaveconsulting.com/report/south-korea-drug-delivery-devices-market/report-sample
Opportunity - Growing Prevalence of Chronic Diseases
The growing prevalence of various chronic diseases, including diabetes, heart disease, cancer, and chronic respiratory diseases, is emerging as the major driving factor for South Korea Drug Delivery Market. As a result, the need for long-term treatment of these health issues is rising in the country. The demand for drug delivery systems is increasing at a high rate for targeted drug delivery, boosting the efficacy of drugs and reducing toxicity. Targeted drug delivery methods frequently call for fewer doses or administrations, which can increase patient compliance and guarantee that medicine is taken as directed.
Impact of Escalating Geopolitical Tensions on South Korea Drug Delivery Devices Market
Escalating geopolitical tensions could negatively impact the growth of South Korea Drug Delivery Devices Market. The Drug Delivery Devices Market in South Korea is disrupted by geopolitical tensions and wars, which results in a lack of raw materials and components and a spike in price. The market depends a great deal on imports of important items and components in drug delivery devices. However, trade constraints, like sanctions, might force domestic and international pharmaceutical companies operating to coordinate their operations with the new regulatory standards. This could result in a slower rate of market introduction for new products.
Diagnostic Centers Segment to Register Fastest CAGR
During the forecast period, the diagnostic centers segment is expected to grow at the fastest CAGR in South Korea Drug Delivery Devices Market by end user. Drug delivery devices are used in diagnostic centers to deliver drugs in a controlled and targeted manner for various purposes, including prevention of STIs and pregnancy, treatment of tuberculosis (TB), and others. The other major end user segments in South Korea Drug Delivery Devices Market include hospitals, ambulatory surgery centers/clinics, and home care settings.
Competitive Landscape
South Korea Drug Delivery Devices Market is intensely competitive, as a number of companies are competing to gain a significant market share. Key players in the market include Bayer, Baxter International, GlaxoSmithKline, 3M Company, Pfizer Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co., Novartis AG, and Quad Medicine.
To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and South Korea Drug Delivery Devices Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in South Korea Drug Delivery Devices Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
Scope of the Report
Attributes |
Details |
Years Considered |
Historical Data – 2019–2023 |
Base Year – 2023 |
|
Estimated Year – 2024 |
|
Forecast Period – 2024–2030 |
|
Facts Covered |
Revenue in USD Million |
Product/ Service Segmentation |
Product Type, Application, End User |
Key Players |
Bayer, Baxter International, GlaxoSmithKline, 3M Company, Pfizer Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co., Novartis AG, Quadmedicine |
About Us
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing qualitative and quantitative data to boost the performance of your business solutions. BlueWeave has built its reputation by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
Contact Us:
BlueWeave Consulting & Research Pvt Ltd
+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662
Get Help
Related Report
Publish Date: October 2024
The South Korean Government’s support to promote development and adoption of medical devices and rising healthcare expenditures are expected to boost the growth of South Korea Drug Delivery Devices Market during the forecast period between 2024 and 2030.
Relevant Press Releases
- Global Animal Wound Care Market Showing Steady Growth: Projected to Grow at a CAGR of 5.9% During the Forecast Period
- Global Nerve Repair and Regeneration Market Is Thriving Amid the Pandemic: Projected to Reach USD 10.7 Billion By 2027
- Asia Pacific Lancet and Pen Needles Market Size More Than Doubles at Significant CAGR of 11.53% to Cross USD 3 Billion by 2030
- India Pulse Oximeter Market to Grow at over 10% until 2028
- Global Glow Discharge Mass Spectrometry (GD-MS) Market Size Set to Grow at Steady CAGR of 7.78% Touching USD 392.15 Million by 2029